Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Susana Keeshin"'
Autor:
Karyn Parsons, Sarah D. Cipriano, Lindsey B. Rosen, Sarah K. Browne, Jolan E. Walter, Bryan L. Stone, Susana Keeshin, Karin Chen
Publikováno v:
Frontiers in Pediatrics, Vol 7 (2019)
With the accessibility of next-generation sequencing modalities, an increasing number of primary immunodeficiency disorders (PIDDs) such as common variable immunodeficiency (CVID) have gained improved understanding of molecular pathogenesis and disea
Externí odkaz:
https://doaj.org/article/dd690f51cf20497f9e759a817314e298
Autor:
Anna K Person, Wendy S Armstrong, Tyler Evans, John J W Fangman, Robert H Goldstein, Marwan Haddad, Mamta K Jain, Susana Keeshin, Hansel E Tookes, Andrea L Weddle, Judith Feinberg
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 76(1)
While we have the tools to achieve this goal, the persistent barriers to healthcare services experienced by too many individuals will need to be addressed to make significant progress and improve the health and quality of life of all people with huma
Autor:
Judith Feinberg, Susana Keeshin
Publikováno v:
Annals of internal medicine. 175(6)
Since July 2017, when In the Clinic last addressed management of HIV infection, there have been meaningful improvements in our ability to prevent HIV and to manage patients living with HIV. New approaches to preexposure prophylaxis and more effective
Publikováno v:
JAMA Network Open
Key Points Question Are universal hepatitis C virus (HCV) screening for all US adults aged 18 years or older and targeted HCV screening among people who inject drugs cost-effective for limiting HCV infection? Findings In this economic evaluation stud
Autor:
Judith Feinberg, Susana Keeshin
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 16 (2017)
HIV infected patients have higher rates of HPV infection, worse disease progression, increase severity of disease, and are at higher risk for intraepithelial neoplasia and cancer than their HIV negative counterparts. We conducted a yearlong pilot pro
Autor:
Judith Feinberg, Susana Keeshin
Publikováno v:
The American Journal of the Medical Sciences. 352:609-614
We examined discharges for infective endocarditis (IE) at an academic teaching hospital for over 10 years to evaluate if an increase in hospitalizations for IE and increase in hepatitis C virus (HCV) in patients with IE could predict a new epidemic o
Publikováno v:
Open Forum Infectious Diseases
Background Despite the clear preventive benefits of HIV Pre-Exposure Prophylaxis (PrEP), uptake among populations at highest risk of HIV acquisition has been limited by lack of health insurance and access to care. In March 2018 we opened a free PrEP
Autor:
Monica Schwarz Josten, Susana Keeshin
Publikováno v:
Open Forum Infectious Diseases
Background In 2015, over half of sexually transmitted infections (STI) and 22% of new HIV infections were among youth aged 15–24. Latest Utah data from 2014 showed this group accounted for 62% of chlamydia, 33% of gonorrhea, and 12% of new HIV infe
Autor:
Judith Feinberg, Susana Keeshin
Publikováno v:
Annals of Internal Medicine. 167:ITC1
No field in medicine has moved as swiftly as HIV/AIDS over the past 35 years. Because of the rapid turnover of key information, this In the Clinic focuses on essential principles of care for newly diagnosed adults with HIV-1 infection and how to prev
Autor:
Judith Feinberg, Susana Keeshin
Publikováno v:
Expert opinion on drug safety. 14(1)
Introduction: Dolutegravir (DGV) is the newest integrase inhibitor approved for the treatment of HIV-1 infection in both treatment-naive and experienced adults and adolescents. This article reviews the safety of DGV for the treatment of HIV-1 infecti